Mark L. Berch

Array ( [id] => 6428801 [patent_doc_number] => 20100168414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'PROCESSES FOR PREPARING EZETIMIBE AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/295442 [patent_app_country] => US [patent_app_date] => 2007-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2778 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168414.pdf [firstpage_image] =>[orig_patent_app_number] => 12295442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6631747 [patent_doc_number] => 20100004446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Process for the Preparation of Abacavir' [patent_app_type] => utility [patent_app_number] => 12/443378 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2928 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004446.pdf [firstpage_image] =>[orig_patent_app_number] => 12443378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676910 [patent_doc_number] => 20080214541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'COMPOSITIONS AND METHODS FOR INDUCING OSTEOGENESIS' [patent_app_type] => utility [patent_app_number] => 11/858827 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14941 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214541.pdf [firstpage_image] =>[orig_patent_app_number] => 11858827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786476 [patent_doc_number] => 20080139805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Process for producing carbapenem derivative having a 1-alkylpyrrolidine structure' [patent_app_type] => utility [patent_app_number] => 11/901942 [patent_app_country] => US [patent_app_date] => 2007-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15580 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139805.pdf [firstpage_image] =>[orig_patent_app_number] => 11901942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544846 [patent_doc_number] => 20100016274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'BETA-LACTAM CANNABINOID RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/441231 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 50907 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016274.pdf [firstpage_image] =>[orig_patent_app_number] => 12441231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922572 [patent_doc_number] => 20080070888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'AZETIDINE AND AZETIDONE DERIVATIVES USEFUL IN TREATING PAIN AND DISORDERS OF LIPID METABOLISM' [patent_app_type] => utility [patent_app_number] => 11/854620 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52218 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070888.pdf [firstpage_image] =>[orig_patent_app_number] => 11854620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201133 [patent_doc_number] => 08188100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Adenosine derivatives as A2A receptor agonists' [patent_app_type] => utility [patent_app_number] => 12/310254 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17259 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188100.pdf [firstpage_image] =>[orig_patent_app_number] => 12310254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939431 [patent_doc_number] => 20080076750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Azetidinone Derivatives and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/854738 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31937 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076750.pdf [firstpage_image] =>[orig_patent_app_number] => 11854738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939432 [patent_doc_number] => 20080076751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Azetidinone Derivatives and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/854754 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50880 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076751.pdf [firstpage_image] =>[orig_patent_app_number] => 11854754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922574 [patent_doc_number] => 20080070890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Spirocyclic Azetidinone Compounds and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/854746 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27746 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070890.pdf [firstpage_image] =>[orig_patent_app_number] => 11854746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922573 [patent_doc_number] => 20080070889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'AZETIDINE AND AZETIDONE DERIVATIVES USEFUL IN TREATING PAIN AND DISORDERS OF LIPID METABOLISM' [patent_app_type] => utility [patent_app_number] => 11/854711 [patent_app_country] => US [patent_app_date] => 2007-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37939 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070889.pdf [firstpage_image] =>[orig_patent_app_number] => 11854711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740644 [patent_doc_number] => 20080234297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'HSP90 Inhibitors Containing a Zinc Binding Moiety' [patent_app_type] => utility [patent_app_number] => 11/852437 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27501 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234297.pdf [firstpage_image] =>[orig_patent_app_number] => 11852437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772695 [patent_doc_number] => 20080058354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Xanthine Phosphodiesterase V Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/852638 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15178 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058354.pdf [firstpage_image] =>[orig_patent_app_number] => 11852638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4565891 [patent_doc_number] => 07846920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Heterosubstituted N-thiolated beta-lactam compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 11/852100 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 3819 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846920.pdf [firstpage_image] =>[orig_patent_app_number] => 11852100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445919 [patent_doc_number] => 20100144738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'INHIBITORS OF C-MET AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/439491 [patent_app_country] => US [patent_app_date] => 2007-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21620 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144738.pdf [firstpage_image] =>[orig_patent_app_number] => 12439491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231405 [patent_doc_number] => 20070293513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound' [patent_app_type] => utility [patent_app_number] => 11/892597 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7651 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293513.pdf [firstpage_image] =>[orig_patent_app_number] => 11892597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281962 [patent_doc_number] => 07553962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 11/895369 [patent_app_country] => US [patent_app_date] => 2007-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17116 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553962.pdf [firstpage_image] =>[orig_patent_app_number] => 11895369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746243 [patent_doc_number] => 20080090845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Haloalkyl-substituted pyrimidinone derivatives' [patent_app_type] => utility [patent_app_number] => 11/895266 [patent_app_country] => US [patent_app_date] => 2007-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26584 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090845.pdf [firstpage_image] =>[orig_patent_app_number] => 11895266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922618 [patent_doc_number] => 20080070934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'KW-3902 CONJUGATES THAT DO NOT CROSS THE BLOOD-BRAIN BARRIER' [patent_app_type] => utility [patent_app_number] => 11/842838 [patent_app_country] => US [patent_app_date] => 2007-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19279 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070934.pdf [firstpage_image] =>[orig_patent_app_number] => 11842838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807471 [patent_doc_number] => 20080171049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/894364 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14148 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171049.pdf [firstpage_image] =>[orig_patent_app_number] => 11894364 [rel_patent_id] =>[rel_patent_doc_number] =>)